Alzheimer's drug candidate REM0045392 put to safety test in healthy volunteers
NCT ID NCT07016464
First seen Dec 16, 2025 · Last updated May 30, 2026 · Updated 26 times
Summary
This early-stage study tested whether a new medicine called REM0045392, being developed for Alzheimer's disease, is safe and tolerable in healthy people. It involved 19 healthy men and older adults who took either the medicine or a placebo, with doses increased over time. The study also looked at how food affects the medicine's levels in the blood. The trial was terminated early, and no results are available yet.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
SGS Belgium NV - Clinical Pharmacology Unit
Edegem, 2650, Belgium
Conditions
Explore the condition pages connected to this study.